Page last updated: 2024-08-23

freedom and piperidines

freedom has been researched along with piperidines in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
McCarthy, L2
Case, M; Doty, EG; Dowsett, SA; Krege, JH; Pohl, G; Tepper, SJ1
Croop, R; L'Italien, GJ; Stock, DA1
Baygani, SK; Hauck, PM; Krege, JH; Lipton, RB; Loo, LS; Pearlman, EM; Tepper, SJ; Vasudeva, R1

Other Studies

5 other study(ies) available for freedom and piperidines

ArticleYear
Orally disintegrating rimegepant increased freedom from pain and from most bothersome symptom at 2 h in acute migraine.
    Annals of internal medicine, 2019, 11-19, Volume: 171, Issue:10

    Topics: Double-Blind Method; Freedom; Humans; Migraine Disorders; Pain; Piperidines; Pyridines; Tablets

2019
Oral rimegepant increased freedom from pain and from most bothersome symptom at 2 h in acute migraine.
    Annals of internal medicine, 2019, 11-19, Volume: 171, Issue:10

    Topics: Calcitonin Gene-Related Peptide Receptor Antagonists; Freedom; Humans; Migraine Disorders; Pain; Piperidines; Pyridines

2019
Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant.
    Headache, 2020, Volume: 60, Issue:8

    Topics: Benzamides; Freedom; Humans; Pain; Piperidines; Pyridines; Pyrroles

2020
Pain Freedom at 2-8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant: A Response.
    Headache, 2020, Volume: 60, Issue:10

    Topics: Benzamides; Freedom; Humans; Pain; Piperidines; Pyridines; Pyrroles

2020
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN.
    The journal of headache and pain, 2021, Aug-28, Volume: 22, Issue:1

    Topics: Benzamides; Double-Blind Method; Freedom; Headache; Humans; Migraine Disorders; Piperidines; Pyridines; Treatment Outcome

2021